<DOC>
	<DOCNO>NCT01453777</DOCNO>
	<brief_summary>The intent clinical study answer question : 1 . Is propose treatment safe 2 . Is treatment effective improve disease pathology patient diffuse brain lesion clinical outcome .</brief_summary>
	<brief_title>Safety Effects Autologous Adipose-Derived Stromal Cells Patients With Diffuse Lesions Brain</brief_title>
	<detailed_description>This open-label , non-randomized multi-center patient sponsor study Adipose-Derived Stromal Cells ( ASC ) implantation use catheter delivery system . ASCs derive patient 's adipose-derived tissue . Liposuction use local anesthesia syringe collection perform collect adipose tissue specimen subsequent process isolate stem cell . The cell deliver via catheter internal carotid artery intravenously .</detailed_description>
	<criteria>Males Females Age 18 80 year . Patient current diagnosis Diffuse Brain Lesions cognitive and/or functional impairment MRI show gross atrophy pathology brain . Up date age gender appropriate cancer screen per American Cancer Society Contraindication MRI General medical contraindication minor surgery angiography Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study Life expectancy &lt; 6 month due concomitant illness . Exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study . Active infectious disease . Patients know tested positive expert consult patient eligibility base patient 's infectious status Any illness , Investigator 's judgment , interfere patient 's ability comply protocol , compromise patient safety , interfere interpretation study result Patients chronic immunosuppressive transplant therapy Systolic blood pressure ( supine ) â‰¤90 mmHg ; Resting heart rate &gt; 100 bpm ; Active clinical infection within one week enrollment . Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last five year . Unwilling and/or able give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>diffuse brain lesion</keyword>
</DOC>